We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Prison term exceeds that handed to former business partner Elizabeth Holmes of failed blood-testing start-up
Judge rules that scientific evidence provided by the claimants was flawed
US judge dismisses almost 2,500 lawsuits alleging links between heartburn medication and cancer
‘Healthy life expectancy’ is an important measure of what people want — and in the UK, it’s not looking good
Health workers in England and Wales reach their limit as rising costs compound a decade of austerity
People must not be constrained by resource from making the choice they want
Government to let nurses and doctors rejoin retirement scheme as health service contends with record waiting lists
New research shows work-related stress and health issues are rising, but flexibility and support from managers can help
Isomorphic Labs poaches pharmaceutical talent as it moves closer to securing first commercial deal
Lars Lannfelt had a key role in developing a drug that has shown some promise in tackling Alzheimer’s
Dementia drug development, diagnostics and delivery still require much more investment
Joe Biden’s coronavirus tsar says Chinese vaccines are ‘not as good’ as alternatives
Northwest Biotherapeutics claims Citadel Securities, Virtu and others drove down its share price
A programme to improve nutrition in schools in Córdoba, Argentina, aims to boost health and the local economy
Demand has been weak for Hong Kong listings — a factor that should temper the Chinese insurer’s price expectations
Japanese company refuses to rule out possibility treatment contributed to brain bleeds
Mistakes by staff at Immensa clinic resulted in incorrect test results, finds disease protection agency
Cepi releases blueprint to move three times faster against a new virus than during Covid-19 pandemic
A story of cancer scares, secretive short sellers, psychological tape bombs and post-investment stress disorder
Shares fall 11% following two patient deaths in trials of lecanemab
Patients and the pursuit of profit, climate tech pioneers, and what links Silicon Valley and the rainforest
The early death of an Alzheimer’s patient taking part in lecanemab trials sent shares down
A sharp drop in local shares highlights the risks stemming from unpredictable politics
What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon. Also: counting the cost of rising long-term sickness on the economy; how organisations can tackle rising levels of exhaustion and retain staff; workspace designers are going all out on domesticity
The business case for better pay and secure hours is compelling — improved recruitment, retention, employee relations and reputational enhancement
International Edition
